Fetal and Neonatal Monitoring Devices Market Report 2026

The fetal and neonatal monitoring devices market size has grown strongly in recent years. It will grow from $9.92 billion in 2025 to $10.6 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increasing institutional childbirth rates, expansion of neonatal intensive care units, rising focus on maternal and infant health outcomes, growing adoption of electronic fetal monitoring, availability of advanced neonatal care equipment.

The fetal and neonatal monitoring devices market size is expected to see strong growth in the next few years. It will grow to $13.57 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing investments in smart maternity care solutions, rising demand for remote patient monitoring, expansion of neonatal care infrastructure in emerging markets, growing focus on early diagnosis of complications, increasing adoption of ai-assisted monitoring systems. Major trends in the forecast period include increasing adoption of continuous fetal monitoring systems, rising use of advanced neonatal vital sign monitors, growing integration of wireless monitoring technologies, expansion of portable monitoring devices, enhanced focus on early risk detection.

The rising prevalence of preterm births is expected to drive the growth of the fetal and neonatal monitoring devices market in the coming years. Preterm birth refers to the early delivery of a child before 37 weeks of gestation, often resulting in poor health, growth issues, mental retardation, visual and hearing impairments, cerebral palsy, and other complications. The increase in preterm births is largely due to more frequent medical interventions for maternal or fetal complications, such as preeclampsia or intrauterine growth restriction, which can lead to early labor induction or cesarean delivery. Fetal and neonatal monitoring devices play a crucial role in managing preterm births and low birth weight infants by continuously monitoring vital signs and health parameters. This enables early detection of complications and timely medical interventions, improving survival rates and long-term health outcomes. For example, in January 2025, the Department of Health and Social Care, a UK-based government agency, reported that 8.1% of all births in England in 2023 were preterm, occurring between 24 and 36 weeks of gestation, with the global average being around 10%. As such, the growing prevalence of preterm births and low birth weight infants is driving the demand for fetal and neonatal monitoring devices.

Leading companies in the fatty acid market are placing a strong emphasis on innovation by introducing cutting-edge devices like the Neonatal Care Warmer Babyroo TN300 to strengthen their market positions. The Neonatal Care Warmer, also known as an infant radiant warmer, is a medical apparatus designed to create a controlled and warm environment for newborn infants, especially those born prematurely or with specific medical needs. In a notable development, Dräger, a German-based company renowned for its gas detection and analysis systems, as well as respiratory and protective equipment, unveiled the Neonatal Care Warmer Babyroo TN300 in June 2023. The Babyroo TN300 represents a significant advancement in newborn care within labor and delivery rooms, as well as Neonatal Intensive Care Units (NICUs). This open-care warmer is equipped with resuscitation tools and offers a customizable design with state-of-the-art thermoregulation capabilities. The pre-warming function ensures that the mattress is prepared at the optimal temperature for newborns, underscoring the product's commitment to providing a secure and comfortable environment for these infants.

In April 2024, AngelEye Health, a US-based leader in neonatal and pediatric family engagement technology, finalized its acquisition of NICU2Home for an undisclosed amount. Through this acquisition, AngelEye aims to broaden its range of neonatal intensive care unit (NICU) solutions by integrating NICU2Home’s discharge management and family engagement app with its existing camera and data insight platform. This will create a unified ecosystem that enhances communication, optimizes NICU navigation, and simplifies the transition from hospital to home for both families and care teams. NICU2Home, a US-based company, provides mobile technology designed to improve parent engagement and care coordination, including fetal and neonatal monitoring devices.

Major companies operating in the fetal and neonatal monitoring devices market are GE Healthcare, Fisher & Paykel Healthcare Limited, Philips Healthcare, Atom Medical Corporation, Natus Medical Incorporated, Phoenix Medical Systems (P) Ltd., Becton Dickinson and Company, Masimo Corporation, Drägerwerk AG & Co. KGAA, CareFusion Corporation, Nonin Medical, Koninklijke Philips N.V., Welch Allyn Inc., Spacelabs Healthcare, Smiths Medical Inc., Getinge AB, FUJIFILM SonoSite Inc., Siemens Healthcare GMBH, Utah Medical Products Inc., Neoventa Medical AB, International Biomedical Ltd., Medtronic Plc, Hill-Rom, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., CooperSurgical Inc., Huntleigh Healthcare Limited, Nihon Kohden Corporation, Arjohuntleigh Healthcare India Private Limited, Advanced Instrumentations, Dixion Vertrieb medizinischer Geräte GmbH, Mediana Co. Ltd., NCC Medical Co. Ltd.

Asia-Pacific was the largest region in the global fetal and neonatal monitoring devices and equipment market in 2025. North America was the second-largest region in the fetal and neonatal monitoring devices and equipment market. The regions covered in the fetal and neonatal monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the fetal and neonatal monitoring devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.

Tariffs are impacting the fetal and neonatal monitoring devices market by increasing costs of imported sensors, imaging components, monitoring electronics, and precision assemblies used in fetal and neonatal care systems. Hospitals and maternity centers in North America and Europe are most affected due to reliance on imported monitoring equipment, while Asia-Pacific faces cost pressure on export-oriented device manufacturing. These tariffs are raising equipment acquisition costs and slowing technology upgrades. However, they are also encouraging domestic production, localized assembly, and innovation in cost-effective and portable monitoring solutions.

The fetal and neonatal monitoring devices market research report is one of a series of new reports that provides fetal and neonatal monitoring devices market statistics, including fetal and neonatal monitoring devices industry global market size, regional shares, competitors with a fetal and neonatal monitoring devices market share, detailed fetal and neonatal monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the fetal and neonatal monitoring devices industry. This fetal and neonatal monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Fetal and neonatal monitoring devices play a crucial role in assessing the health of both expectant mothers and newborns. These devices are employed to monitor vital parameters during pregnancy and childbirth, ensuring the well-being of both the fetus and neonate.

The equipment in the fetal and neonatal monitoring devices and equipment category can be categorized as either fetal or neonatal monitoring tools. Fetal monitoring equipment includes ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. On the other hand, neonatal monitoring equipment encompasses infant warmers, incubators, convertible warmers, incubators, phototherapy equipment, respiratory devices, neonatal monitoring devices, and diagnostic imaging devices. These monitoring devices are utilized by various healthcare facilities, including hospitals, diagnostic centers, pediatric clinics, and ambulatory surgical centers, to ensure the health and safety of pregnant women and newborns throughout the childbirth process.

The fetal and neonatal monitoring devices market consists of sales of instruments such as ultrasound devices, fetal dopplers, fetal MRI systems, fetal monitors, and fetal pulse oximeters. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.